This is the personal website of Devin Coldewey, Seattle-based writer and photographer. He can be reached at devin at techcrunch dot com (direct pitches and appearance requests here, please) or devin at this domain (for personal correspondence; pitches will be deleted with prejudice).
Devin currently writes for TechCrunch, covering many topics in technology, science, and space; he has written for MSNBC.com, NBC News, DPReview, and others; he has also appeared on radio, television, and in print.
Devin’s latest stories are below. More can be found at his author page at TechCrunch.
- Google Stadia is now free for everyone, with a two-month trial for Pro tierGoogle’s game-streaming service Stadia is now free for anyone with a Google account, the company announced today. Assuming you’ve got a compatible device and controller — and good internet in one of the 14 supported countries — you can sign…
- NASA puts $7M toward long-shot research, from moon mining to solar lensesNASA’s Innovative Advanced Concepts program is all about making high-risk, high-reward bets on unique — and sometimes eyebrow-raising — ideas for space exploration and observation. This year’s grants total $7 million and include one of the most realistic projects yet.…
- White House signals support for a new international Moon TreatyThe international community has struggled for decades to formalize rules regarding the collection and use of resources in space and on the Moon. While the U.S. and all spacefaring countries declined to endorse the most famous attempt, the 1979 “Moon…
- FCC shoots down petition to label Trump’s coronavirus broadcasts as hoaxesThe FCC has denied a request that it investigate and take action on a broadcast the petitioners allege has made material and deadly contributions to the spread of COVID-19: President Trump’s frequent press conferences. In a petition filed with the…
- R&D Roundup: Ultrasound/AI medical imaging, assistive exoskeletons and neural weather modelingIn the time of COVID-19, much of what transpires from the science world to the general public relates to the virus, and understandably so. But other domains, even within medical research, are still active — and as usual, there are…